| __timestamp | Amgen Inc. | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 79435000 |
| Thursday, January 1, 2015 | 4070000000 | 162644000 |
| Friday, January 1, 2016 | 3840000000 | 237939000 |
| Sunday, January 1, 2017 | 3562000000 | 168435000 |
| Monday, January 1, 2018 | 3737000000 | 173797000 |
| Tuesday, January 1, 2019 | 4116000000 | 113842000 |
| Wednesday, January 1, 2020 | 4207000000 | 747027000 |
| Friday, January 1, 2021 | 4819000000 | 2534508000 |
| Saturday, January 1, 2022 | 4434000000 | 1235278000 |
| Sunday, January 1, 2023 | 4784000000 | 737502000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Amgen Inc. and Novavax, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Amgen consistently allocated substantial resources to R&D, with an average annual expenditure of approximately $4.2 billion. This commitment underscores Amgen's dedication to maintaining its leadership in the biotech sector. Notably, Amgen's R&D spending peaked in 2021, reflecting a strategic push during a pivotal year for the industry.
Conversely, Novavax's R&D spending, while significantly lower, saw a dramatic increase in 2021, surging by over 1,200% compared to 2014. This spike aligns with Novavax's pivotal role in developing COVID-19 vaccines, highlighting the company's agile response to global health challenges.
These trends reveal the diverse approaches of two biotech giants in navigating the complexities of innovation and market demands.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Research and Development Expenses Breakdown: Amgen Inc. vs Genmab A/S
Research and Development Expenses Breakdown: Amgen Inc. vs Madrigal Pharmaceuticals, Inc.
Amgen Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Novavax, Inc.
R&D Spending Showdown: Zoetis Inc. vs Novavax, Inc.
Biogen Inc. or Novavax, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Novavax, Inc.
R&D Insights: How Opthea Limited and Novavax, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Novavax, Inc.
Analyzing R&D Budgets: Iovance Biotherapeutics, Inc. vs Novavax, Inc.